January 26, 2018 — LivaNova PLC and MicroPort Scientific Corp. announced the companies have entered into a binding Letter of Intent (LOI) for the sale of LivaNova’s Cardiac Rhythm Management (CRM) business franchise to MicroPort for $190 million in cash.

Medtronic plc announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will evaluate the safety and effectiveness of the Abre stent in subjects with iliofemoral venous outflow obstruction. The first procedure was performed in December of 2017, by Erin Murphy, M.D., director of the venous and lymphatic program at Carolinas HealthCare System’s Sanger Heart & Vascular Institute in Charlotte, N.C., and national principal investigator for the ABRE IDE Study in the United States.

January 25, 2018 – Modalixx G202MDL is a new grayscale High Bright medical LCD solution for modality CRT monitor replacement, with the ability to autosync to any legacy grayscale or color analog modality and up-scales it to megapixel resolution. With a complete set of input options, the device is compatible with nearly all medical modality applications. Modalixx G202MDL covers cath lab, magnetic resonance imaging (MRI), computed tomography (CT), RF rooms, C-Arm, and Portable X-ray, applications.

January 25, 2018 – Canon Medical Systems, in partnership with Quality Electrodynamics (QED), installed a Vantage Galan 3T MR system at the new QED Research Center in Mayfield Village, Ohio.

January 25, 2018 – Penumbra Inc. today announced results of the company-sponsored PROMISE Study, demonstrating real-world safety and efficacy of the Penumbra System with ACE68 and ACE64 Reperfusion Catheters as frontline treatment in patients with acute ischemic stroke using the ADAPT (A Direct Aspiration First Pass Technique) approach.

January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study. The results of the Endovascular Therapy Following Imaging Evaluation for the Ischemic Stroke (DEFUSE 3) trial, presented at the International Stroke Conference 2018 in Los Angeles and published on Jan.

January 25, 2018 – According to the latest market study released by Technavio, the global circulatory support devices market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the forecast period.

January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Catheterization accreditation program. Facilities now have the ability to access the published “IAC Standards and Guidelines for Cardiovascular Catheterization Accreditation” and submit applications for accreditation.

January 25, 2018 – Data presented at the Biotronik-sponsored symposium on the Orsiro drug-eluting stent (DES) demonstrate why Orsiro is gaining prominence in the crowded DES market.

January 25, 2018 – Elixir Medical Corporation, a leader in the development of breakthrough adaptive remodeling technologies designed to mimic the normal arterial function after cardiovascular and peripheral vascular disease intervention, unveiled for the first time its novel stent technology, DynamXTM, a bioadaptive drug-eluting stent (BA-DES) platform at the Tr

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now